Brian Burgess > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices

1900 N Street NW
Washington, District of Columbia 20036
United States
- Firm Profile
- Go to...
Brian Burgess

Position
Partner
Career
Brian Burgess is a partner in Goodwin’s Litigation Department and Appellate and Supreme Court Litigation practice, co-chairs the firm’s FDA Litigation practice (which was honored by LMG in 2022 as the FDA Litigation & Enforcement Firm of the Year) and is a member of the firm’s Life Sciences Disputes group. His work focuses on appellate matters and complex civil litigation in federal courts, and he has experience in a wide range of areas including antitrust law, administrative law (with a particular focus on FDA litigation), constitutional law, intellectual property and financial services litigation. Brian has argued appeals in numerous courts, including twice in the U.S. Supreme Court.
Brian is recognized in Chambers USA: America’s Leading Lawyers for Business as an “Up and Coming” attorney in the Nationwide Appellate Rankings, where he is noted in particular for “expertise in advising life sciences clients in disputes work.” Clients laud Brian for providing “timely and helpful advice across a variety of issues” and describe him as “a tremendous up-and-coming litigator” with “the unique skill of taking complicated controversial topics and making them simple, understandable and logical.” Another client notes that Brian is “a phenomenal lawyer with an impressive command of a variety of issues” and describes him as “a good writer and a strong oral advocate” with “tremendous drive.” Brian has also been named to Benchmark Litigation’s “40 & Under Hot List” for six consecutive years, from 2017-2022 and is a recommended lawyer for appellate by the Legal 500. In 2020, Brian was named a “D.C. Rising Star” by the National Law Journal.
Prior to joining Goodwin, Brian served as a law clerk to Associate Justice Sonia Sotomayor of the Supreme Court of the United States. He previously worked in the Department of Justice as a special assistant to the Solicitor General.
Education
J.D., 2009 New York University (summa cum laude) / A.B., 2005 Dartmouth College (summa cum laude)
Lawyer Rankings
United States > Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
The team at Goodwin is well-versed in representing life sciences and tech companies in patent and licensing disputes, as well as ERISA and class action appeals. The group is also routinely engaged in immigration and financial services cases. Leadership is shared between William Jay and Jaime Santos, both of whom are based in Washington, D.C.; and Boston-based Kevin Martin. Jay draws on notable experience arguing patent, copyright, and trademark cases before the Supreme Court, as well as handling constitutional law, securities, financial services, and class action mandates. Younger partner Santos focuses on appellate matters and has experience in ERISA litigation, patent litigation and product litigation. Martin, for his part, has been engaged in recent years on federal and state appellate court cases that have included successfully representing Workhuman in a case involving questions of statutory interpretation under Florida’s Private Whistleblower Act. D.C.-based Brian Burgess and Boston-based David Zimmer are additional key contacts. Gerard Cedrone left the firm for the Massachusetts State Solicitor’s Office in November 2024.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation